Harshad R. Kulkarni, MD is Chief Medical Advisor at BAMF Health Theranostics Center in Grand Rapids and Clinical Associate Professor of Radiology at the Michigan State University College of Human Medicine. He is nuclear medicine physician with vast clinical, research and teaching experience from Germany in theranostic oncology, specialising in molecular imaging, dosimetry and targeted alpha- and beta-emitting radiopharmaceutical therapy of prostate cancer, and neuroendocrine neoplasms, as well as Theranostics for thyroid diseases. He has been lead investigator of several major radiopharmaceutical clinical trials, including first-in-human studies with novel radiopharmaceutical targeting.